Peter Friedmann to Antiviral Agents
This is a "connection" page, showing publications Peter Friedmann has written about Antiviral Agents.
Connection Strength
1.108
-
Friedmann PD, Wilson D, de Gijsel D, Nolte K, Dejace J, Hoskinson R, Del Toro-Mejias L, Bianchet E, Dowd P, Soares WE, Stopka TJ. Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs: A Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 02; 9(1):e2555125.
Score: 0.773
-
Bianchet E, de Gijsel D, Del Toro-Mejias LM, Stopka TJ, Hoskinson RA, Dowd P, Friedmann PD. More than Just Buying a Van: Lessons Learned from a Mobile Telehealth HCV Testing and Treatment Study. Viruses. 2024 08 30; 16(9).
Score: 0.176
-
Cioe PA, Stein MD, Promrat K, Friedmann PD. A comparison of modified directly observed therapy to standard care for chronic hepatitis C. J Community Health. 2013 Aug; 38(4):679-84.
Score: 0.082
-
Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med. 2012 Sep; 6(3):179-85.
Score: 0.077